AnaCardio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for heart failure. By harnessing cutting-edge science, AnaCardio aims to create novel drugs that enhance patient outcomes and transform heart failure treatment, addressing a critical need in cardiovascular healthcare.
National Ranking743rd
in Sweden Regional Ranking17317th
in Western Europe Global Ranking68912th
worldwide Rankings by
